Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Jeene

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|September 3, 2025
Radiation PneumonitisMax Peters, Paul Jeene
The Neurologist|November 2, 2012
Cueing for freezing of gait: a need for 3-dimensional cues?Anke H Snijders, Paul Jeene, Maarten J Nijkrake, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2025
Incomplete neoadjuvant chemo(radio)therapy negatively impacts pathological response and overall survival in locally advanced esophageal cancerDenice Kamp, Samuel Noya, Stella Mook, et al.
International Journal of Cancer|November 19, 2025
Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparisonBenthe H Doeve, Steven C Kuijper, Geert Silversmit, et al.
Clinical and Translational Radiation Oncology|January 26, 2024
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E<sup>2</sup>-RADIatE OligoCare cohortRenée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohortFilippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2026
Local control in oligometastatic cancer patients following metastasis-directed stereotactic ablative radiotherapy: An interim analysis of ESTRO EORTC E2-RADIatE OligoCare cohortInes Joye, Umberto Ricardi, Marta Scorsetti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E<sup>2</sup>-RADIatE OligoCare studySebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2023
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in EuropeTiuri E Kroese, Hanneke W M van Laarhoven, Sebastian F Schoppman, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|September 3, 2025
Radiation PneumonitisMax Peters, Paul Jeene
The Neurologist|November 2, 2012
Cueing for freezing of gait: a need for 3-dimensional cues?Anke H Snijders, Paul Jeene, Maarten J Nijkrake, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2025
Incomplete neoadjuvant chemo(radio)therapy negatively impacts pathological response and overall survival in locally advanced esophageal cancerDenice Kamp, Samuel Noya, Stella Mook, et al.
International Journal of Cancer|November 19, 2025
Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population-based comparisonBenthe H Doeve, Steven C Kuijper, Geert Silversmit, et al.
Clinical and Translational Radiation Oncology|January 26, 2024
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E<sup>2</sup>-RADIatE OligoCare cohortRenée Bultijnck, Mieke Van Hemelrijck, Valérie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E<sup>2</sup>-RADIatE OligoCare cohortFilippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2026
Local control in oligometastatic cancer patients following metastasis-directed stereotactic ablative radiotherapy: An interim analysis of ESTRO EORTC E2-RADIatE OligoCare cohortInes Joye, Umberto Ricardi, Marta Scorsetti, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E<sup>2</sup>-RADIatE OligoCare studySebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2022
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in EuropeTiuri E Kroese, Richard van Hillegersberg, Sebastian Schoppmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2023
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in EuropeTiuri E Kroese, Hanneke W M van Laarhoven, Sebastian F Schoppman, et al.
Pageof 2